300 related articles for article (PubMed ID: 33499770)
1. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
[TBL] [Abstract][Full Text] [Related]
2. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
3. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
4. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
5. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
6. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
Hereditas; 2019; 156():20. PubMed ID: 31285741
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
[TBL] [Abstract][Full Text] [Related]
8. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
9. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
10. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
11. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
12. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
13. Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis.
Cai KT; Feng CX; Zhao JC; He RQ; Ma J; Zhong JC
Mol Med Rep; 2018 Dec; 18(6):4994-5008. PubMed ID: 30320391
[TBL] [Abstract][Full Text] [Related]
14. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
[TBL] [Abstract][Full Text] [Related]
15. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
16. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
[TBL] [Abstract][Full Text] [Related]
20. The bioinformatics analysis of miRNAs signatures differentially expressed in HER2(+) versus HER2(-) breast cancers.
Nie W; Jin L; Wang Y; Wang Z; Guan X
Cancer Biother Radiopharm; 2013 Feb; 28(1):71-6. PubMed ID: 23009584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
